TIGIT/PVR/NECTIN immune checkpoint axis expression across breast cancer subtypes.

被引：0
|
作者：
DuPree, Kelly J. [1 ]
Molinero, Luciana [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
483
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Correlation of neutrophil-to-lymphocyte ratio and stromal tumor infiltrating lymphocytes across early breast cancer subtypes.
    Garcia-Torralba, Esmeralda
    Ivars-Rubio, Alejandra
    Perez-Ramos, Miguel
    Navarro Manzano, Esther
    Blaya-Boluda, Noel
    de la Morena Barrio, Pilar
    Garcia-Garre, Elisa
    Marin Zafra, Gema
    Moya Hernandez, Miguel Angel
    Guirao Garcia, Maria Esperanza
    Chaves Benito, Asuncion
    Garcia Martinez, Elena
    Ayala, Francisco
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] TIGIT: An emerging immune checkpoint target for immunotherapy in autoimmune disease and cancer
    Zhao, Junpeng
    Li, Liming
    Yin, Huiqi
    Feng, Xiwei
    Lu, Qianjin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 120
  • [33] Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
    Chu, Carissa E.
    Sjostrom, Martin
    Egusa, Emily A.
    Gibb, Ewan A.
    Badura, Michelle L.
    Zhu, Jun
    Koshkin, Vadim S.
    Stohr, Bradley A.
    Meng, Maxwell, V
    Pruthi, Raj S.
    Friedlander, Terence W.
    Lotan, Yair
    Black, Peter C.
    Porten, Sima P.
    Feng, Felix Y.
    Chou, Jonathan
    CLINICAL CANCER RESEARCH, 2021, 27 (18) : 5123 - 5130
  • [34] Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients
    Li, Cui
    Liu, Haiyan
    Duan, Zhongliang
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [35] Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients
    Cui Li
    Haiyan Liu
    Zhongliang Duan
    BMC Immunology, 25
  • [36] Race, Response to Chemotherapy, and Outcome within Clinical Breast Cancer Subtypes.
    Tichy, J. R.
    Deal, A. M.
    Anders, C. K.
    Carey, L. A.
    CANCER RESEARCH, 2011, 71
  • [37] Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
    Hattori, Norimichi
    Kawaguchi, Yukiko
    Sasaki, Yohei
    Shimada, Shotaro
    Murai, So
    Abe, Maasa
    Baba, Yuta
    Watanuki, Megumi
    Fujiwara, Shun
    Arai, Nana
    Kabasawa, Nobuyuki
    Tsukamoto, Hiroyuki
    Uto, Yui
    Yanagisawa, Kouji
    Saito, Bungo
    Harada, Hiroshi
    Nakamaki, Tsuyoshi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (05) : 861 - 867
  • [38] TIGIT-PVR IS A KEY IMMUNE CHECKPOINT AND THERAPEUTIC TARGET IN HPV-POSITIVE HEAD AND NECK SQUAMOUS CELL CARCINOMAS
    Le, Xiuning
    Dang, Minghao
    Hegde, Venkatesh
    Jiang, Bo
    Slay, Ravaen
    Xiao, Weihong
    Akagi, Keiko
    Fresquez, Joseph
    Marcelo, Kathrina
    Luo, Qianyun
    Sinha, Pragya
    Yanamandra, Ananta
    Bell, Diana
    Williams, Michelle
    Cuentas, Edwin Parra
    Goepfert, Ryan
    Lai, Stephen
    Gross, Neil
    Agrawal, Amit
    Reuben, Alexandre
    Myers, Jeffrey
    Curran, Michael
    Sastry, Jagannadha
    Wang, Linghua
    Gillison, Maura
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A788 - A788
  • [39] Effect of neoadjuvant chemotherapy on immune checkpoint expression in breast cancer.
    Stiff, Andrew
    McQuinn, Christopher
    Wesolowski, Robert
    Lustberg, Maryam B.
    Reinbolt, Raquel E.
    VanDeusen, Jeffrey Bryan
    Sardesai, Sagar D.
    Williams, Nicole Olivia
    Noonan, Anne M.
    Dewani, Shabana Jaynul
    Ramaswamy, Bhuvaneswari
    Carson, William Edgar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Expression of immune checkpoint related genes are prognostic in untreated breast cancer
    Bianchini, G.
    Rossi, C. M.
    Iwamoto, T.
    Karn, T.
    Callari, M.
    Kelly, C. M.
    Pusztai, L.
    Gianni, L.
    CANCER RESEARCH, 2013, 73
12345